Successful results from trial of first-in-class Parkinson’s disease peptide
Researchers uncover how neurons deliver RNA where it is needed
Revvity to acquire Human Cell Design
Engineered immune cells trial to fight colorectal cancer approved
Approval for prostate cancer treatment
Approval for atopic dermatitis treatment
FDA Breakthrough Therapy Designation for Glanzmann Thrombasthenia drug
New company targets dry eye disease with first-in-class therapy
Collaboration to advance novel combination therapy for glioblastoma
Study shows AI boosts breast cancer detection by more than 10 percent
First reliable biomarker test for early kidney transplant rejection detection in living-donor recipients
Approval for drug to treat advanced squamous cell carcinoma of the anal canal